Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.45 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.45 |
| ▸ | GJA1 | P17302 | 1/20 | 0.44 |
| ▸ | GJB2 | P29033 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | IGF2R | P11717 | 1/20 | 0.40 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.40 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16263450 | 0.95 | L3MBTL1 (0.53) | L3MBTL1MEN1KMT2AMAPTLGALS8 | |
| SCHEMBL25140766 | 0.95 | L3MBTL1 (0.53) | L3MBTL1MEN1KMT2AMAPTLGALS8 | |
| SCHEMBL19781814 | 0.95 | L3MBTL1 (0.53) | L3MBTL1MEN1KMT2AMAPTLGALS8 | |
| SCHEMBL25140877 | 0.95 | L3MBTL1 (0.53) | L3MBTL1MEN1KMT2AMAPTLGALS8 | |
| SCHEMBL25705585 | 0.94 | L3MBTL1 (0.46) | L3MBTL1MEN1KMT2AMAPTLGALS8 | |
| SCHEMBL25692868 | 0.94 | L3MBTL1 (0.51) | L3MBTL1MEN1KMT2AMAPTLGALS8 | |
| SCHEMBL19782039 | 0.94 | L3MBTL1 (0.51) | L3MBTL1MEN1KMT2AMAPTLGALS8 | |
| SCHEMBL25140762 | 0.92 | LGALS3 (0.51) | L3MBTL1MEN1KMT2AMAPTLGALS8 | |
| SCHEMBL25692854 | 0.92 | L3MBTL1 (0.53) | L3MBTL1MEN1KMT2AMAPTLGALS8 | |
| SCHEMBL25692944 | 0.92 | L3MBTL1 (0.53) | L3MBTL1MEN1KMT2AMAPTLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192748-A1 | Etoposide Glycosides, Methods Of Making, And Uses Thereof As An Anti-Cancer Drug | DOUBLERAINBOW BIOSCIENCES INC. | 2023-06-22 | — | — | US | disclosed |
| US-20230124589-A1 | Ivacaftor Glycosides, Methods Of Making, And Uses Thereof In Treating Cystic Fibrosis | DOUBLERAINBOW BIOSCIENCES INC. | 2023-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230124589-A1 | Ivacaftor Glycosides, Methods Of Making, And Uses Thereof In Treating Cystic Fibrosis | UGGT1, UGDH, GALE | L3MBTL1 1359/4885MEN1 4138/4885KMT2A 3837/4885 |
| US-20230192748-A1 | Etoposide Glycosides, Methods Of Making, And Uses Thereof As An Anti-Cancer Drug | GALE, UGGT1, DERA | L3MBTL1 1063/4885MEN1 1259/4885KMT2A 2864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.